Tags : Amadeus Capital Partners

Greater London

Doctify secures £5.46 Series A Follow On investment led by

Doctify Raises Further $7.5m in a New Round Led by KEEN Venture Partners LONDON, UK  13 April 2021 – Doctify, a healthcare review platform, today announced an additional $7.5M in its latest funding round, taking the overall investment to $20M. The round was led by KEEN Venture Partners, with participation from existing investors, Amadeus Capital Partners, Guinness […]Read More

East of England

River Lane Research (t/a Riverlane) secures £14.6 million Series A

Quantum computing software specialist, Riverlane secures $20 million in Series A funding New funding will accelerate Riverlane’s mission to build a high-performance operating system that makes quantum computers useful, sooner. CAMBRIDGE, UK, 25 JANUARY, 2021: Riverlane, a quantum software company, today announces that it has raised $20m in Series A funding to build Deltaflow, its […]Read More

Original

Seldon Technologies secures £7.1 million Series A investment co-led by

Seldon raises £7.1M Series A London, 17 November 2020: Seldon, the Open Source DevOps company providing enterprises with the tools to manage, serve and optimise their Machine Learning models at scale, today announces a £7.1M Series A co-led by AlbionVC and Cambridge Innovation Capital. The round also includes significant participation from existing investors Amadeus Capital Partners and Global Brain, […]Read More

East of England

Nu Quantum secures £2.1m Seed investment led by Amadeus Capital

Nu Quantum raises £2.1m Seed investment to accelerate the commercialisation of pioneering quantum photonics hardware Investment in Cambridge-based Nu Quantum will go towards a new state-of-the-art lab, a major recruitment drive, and further R&D for quantum photonics technologies Cambridge, Monday 5th October 2020 – Nu Quantum, the quantum photonics company, has raised £2.1 million in […]Read More

Greater London

Ori Biotech secures £7.19 million Seed investment from Amadeus Capital

Ori Biotech announces a $9.4M Seed Round to advance innovation in Cell and Gene Therapy manufacturing Syndicate includes leading UK investors Amadeus Capital Partners, Delin Ventures and Kindred Capital Appoints Jason C. Foster as Chief Executive Officer January 8, 2020, London, UK and Philadelphia, USA – Ori Biotech Ltd (Ori), an innovator in Cell and Gene […]Read More

Original

Healx secures £43.86 million Series B investment led by Atomico

Healx secures $56M in Series B financing, launches global accelerator programme for rare diseases Latest round of funding, led by Atomico, will be used to build a clinical-stage portfolio for rare diseases, including treatments for fragile X syndrome, the leading genetic cause of autism Healx’s Rare Treatment Accelerator programme is a new initiative launched in […]Read More

Original

Cambridge Touch Technologies secures £8.04 million Series B funding led

CTT set for rapid expansion following oversubscribed $10M Series B rounde Led by Kureha Corporation of Japan, and joined by multinational corporate and VC investors from the UK, Japan and China, funds will be used to accelerate product launch and growth into new markets Cambridge, 23 July 2019 – Cambridge Touch Technologies Ltd. (“CTT”, “the Company”), the leading provider […]Read More